T1	Condition 7 24	co-morbid illness
T2	Qualifier 0 6	Severe
R1	Has_qualifier Arg1:T1 Arg2:T2	
T3	Qualifier 33 44	untreatable
T4	Qualifier 45 50	other
T5	Condition 51 61	malignancy
T6	Qualifier 69 75	active
T7	Condition 76 86	infections
R2	Has_qualifier Arg1:T7 Arg2:T6	
R3	Has_qualifier Arg1:T5 Arg2:T4	
R4	Has_qualifier Arg1:T5 Arg2:T3	
*	OR T5 T7
T8	Scope 33 86	untreatable other malignancy and/or active infections
T9	Scope 0 24	Severe co-morbid illness
R5	Subsumes Arg1:T9 Arg2:T8	
T10	Condition 89 97	Pregnant
T11	Condition 101 110	lactating
T12	Person 111 116	women
*	OR T11 T10
T13	Condition 118 134	Hypersensitivity
T14	Drug 138 149	Sandostatin
T15	Drug 157 185	component of the formulation
*	OR T14 T15
T16	Scope 138 185	Sandostatin or any component of the formulation
R6	Has_scope Arg1:T13 Arg2:T16	
